Cargando…
Treatment of chronic hepatitis B in sub-Saharan Africa: 1-year results of a pilot program in Ethiopia
BACKGROUND: The World Health Organization has set an ambitious goal of eliminating viral hepatitis as a major public health threat by 2030. However, in sub-Saharan Africa, antiviral treatment of chronic hepatitis B (CHB) is virtually unavailable. Herein, we present the 1-year results of a pilot CHB...
Autores principales: | Desalegn, Hailemichael, Aberra, Hanna, Berhe, Nega, Mekasha, Bitsatab, Stene-Johansen, Kathrine, Krarup, Henrik, Pereira, Andre Puntervold, Gundersen, Svein Gunnar, Johannessen, Asgeir |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6296040/ https://www.ncbi.nlm.nih.gov/pubmed/30554571 http://dx.doi.org/10.1186/s12916-018-1229-x |
Ejemplares similares
-
Mother-to-Child Transmission of Hepatitis B Virus in Ethiopia
por: Johannessen, Asgeir, et al.
Publicado: (2021) -
Early experiences from one of the first treatment programs for chronic hepatitis B in sub-Saharan Africa
por: Aberra, Hanna, et al.
Publicado: (2017) -
Predictors of mortality in patients under treatment for chronic hepatitis B in Ethiopia: a prospective cohort study
por: Desalegn, Hailemichael, et al.
Publicado: (2019) -
Are non‐invasive fibrosis markers for chronic hepatitis B reliable in sub‐Saharan Africa?
por: Desalegn, Hailemichael, et al.
Publicado: (2017) -
Dry Blood Spots a Reliable Method for Measurement of Hepatitis B Viral Load in Resource-Limited Settings
por: Stene-Johansen, Kathrine, et al.
Publicado: (2016)